Trial of CF101 to Treat Patients With Psoriasis

NCT01265667 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

293

Enrollment

INDUSTRY

Sponsor class

Conditions

Plaque Psoriasis

Interventions

DRUG: CF101
DRUG: Placebo

Sponsor

Can-Fite BioPharma